The BioSecure Act is set to reshape the regulatory landscape across APAC – and understanding its implications is essential for pharmaceutical, biotech, and medical device companies. Image credit: GlobalData Healthcare.

The regulatory landscape across the Asia-Pacific (APAC) region is evolving rapidly, and pharmaceutical companies must adapt to maintain compliance, mitigate risk, and seize new opportunities. To address these challenges, GlobalData Healthcare is hosting an exclusive webinar on 26 August 2025, providing expert analysis of the BioSecure Act and its implications for the region’s pharma sector.

The BioSecure Act represents a significant shift in regulatory oversight, with the potential to impact clinical operations, research and development, and strategic planning. Pharmaceutical executives, regulatory professionals, and R&D leaders are increasingly seeking actionable insights to anticipate the effects of this legislation on their portfolios and operational models.

Go deeper with GlobalData

Go deeper with GlobalData

The gold standard of business intelligence.

Find out more

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

GlobalData Healthcare, a trusted provider of strategic intelligence to leading healthcare companies, offers a unique perspective on these developments. With years of experience delivering integrated intelligence – from market forecasts to competitive analysis – GlobalData enables companies to make faster, more informed decisions.

The upcoming webinar reflects this mission, combining expert commentary with practical takeaways for stakeholders navigating regulatory complexity in APAC.

Key topics to be covered include:

  • Regulatory implications of the BioSecure Act for pharmaceutical and biotech companies
  • Risk management strategies to ensure operational compliance
  • Opportunities for innovation and strategic advantage in a shifting legislative environment
  • Insights from industry experts on how to align R&D and clinical operations with evolving policy requirements

Attendees will also benefit from the opportunity to engage with GlobalData analysts and gain a forward-looking view of how these regulatory changes may influence market dynamics, competitive positioning, and investment priorities.

As regulatory pressures intensify, proactive intelligence is becoming indispensable for pharmaceutical and biotech companies operating in APAC. This webinar provides the tools and insights needed to navigate the BioSecure Act with confidence, ensuring that organisations remain agile, compliant, and strategically prepared.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

Register now to secure your place and gain a comprehensive understanding of the BioSecure Act’s impact on the APAC pharmaceutical landscape by clicking this link.

Medical Device Network Excellence Awards - Nominations Closed

Nominations are now closed for the Medical Device Network Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact

Excellence in Action
SC MEDICA’s minimally invasive, radiation free spinal facet fixation system, FFX® is transforming spinal pain management and improving outcomes for surgeons and patients alike. Learn how SC MEDICA’s award-winning technology is redefining standards in facet joint pain treatment.

Discover the Impact